IP Library Granted Patent US 10,463,044
Granted Patent B2
US 10,463,044 · App. 15/186,070 · Granted Nov 5, 2019

Molecules that inhibit efflux pumps in multi-drug resistant bacteria and uses thereof

Inventors: George W. Gokel (St. Louis, MO); Michael R. Gokel (St. Louis, MO); Saeedeh Negin (St. Louis, MO); Mohit B. Patel (St. Louis, MO)
A01N43/72A61K31/165A61K31/395A61K31/496A61K31/65A61K45/06A61K38/16A61K2300/00Y02A50/473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,044
App. No.
15/186,070
Granted
Nov 5, 2019
Kind
B2
Abstract

Methods and compositions are provided for increasing or enhancing the efficacy of antibiotics, such as by increasing antimicrobial activity, against a variety of microbes by co-administration with synthetic amphiphiles, including lariat ethers and hydraphiles. Methods and compositions for overcoming antibiotic resistance are also provided.

Claims (9)

1. A method of reversing the resistance of a multi-drug resistant bacterium to an antibiotic by inhibiting efflux pump activity in the multi-drug resistant bacterium, said method comprising administering to said bacterium the antibiotic and a synthetic amphiphile, wherein said synthetic amphiphile is a hydraphile comprising the structure of Formula 4;

 wherein n is 8, 10, 12, or 14; and wherein said hydraphile is administered at a concentration of half or less of its minimum inhibitory concentration (MIC) against the multi-drug resistant bacterium as determined in the absence of the antibiotic.

2. The method of claim 1 , wherein said synthetic amphiphile is administered as an aggregate or in a liposome.

3. The method of claim 1 , wherein said synthetic amphiphile is administered in a protonated or salt form.

4. The method of claim 1 , wherein said bacterium is a bacterium in the family Enterobacteriaceae, in the family Bacillaceae, or in the family Pseudomonadaceae.

5. The method of claim 4 , wherein said bacterium is an efflux pump expressing Gram-positive or Gram-negative bacterium.

6. The method of claim 1 , wherein the antibiotic is administered at a concentration lower than its minimum inhibitory concentration (MIC) against the multi-drug resistant bacterium as determined in the absence of the synthetic amphiphile.

7. The method of claim 1 , wherein the hydraphile is administered at a concentration of 1 nM to 10 μM.

8. The method of claim 6 , wherein the hydraphile is administered at a concentration of 1 nM to 10 μM.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2016
From: GOKEL, GEORGE WILLIAM, JR.; PATEL, MOHIT B; NEGIN, SAEEDEH
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 040146/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2016
From: GOKEL, MICHAEL
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 039857/0639 →
CONFIRMATORY LICENSE Recorded Aug 2, 2016
From: UNIVERSITY OF MISSOURI, ST. LOUIS
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 039537/0318 →
Continuity (3)
Continuation In Part PCTUS2015034550 · Jun 5, 2015
Provisional Application 62008956 · Jun 6, 2014
Related Publication 20160361292A1 · Dec 15, 2016